Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Navin Jacob is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/28/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 02/03/2025 | ABBV | Buy Now | AbbVie | $204.00 | -6.86% | Navin Jacob66% | $181 → $190 | Maintains | Neutral | Get Alert |
| 10/31/2024 | ABBV | Buy Now | AbbVie | $204.00 | -1.96% | Navin Jacob66% | $195 → $200 | Maintains | Neutral | Get Alert |
| 10/09/2024 | ABBV | Buy Now | AbbVie | $204.00 | -4.41% | Navin Jacob66% | $185 → $195 | Maintains | Neutral | Get Alert |
| 07/26/2024 | ABBV | Buy Now | AbbVie | $204.00 | -9.31% | Navin Jacob66% | $172 → $185 | Maintains | Neutral | Get Alert |
| 02/10/2023 | ABBV | Buy Now | AbbVie | $204.00 | -25.49% | Navin Jacob66% | $150 → $152 | Maintains | Neutral | Get Alert |
| 01/31/2023 | ABBV | Buy Now | AbbVie | $204.00 | -26.47% | Navin Jacob66% | $147 → $150 | Maintains | Neutral | Get Alert |
| 10/31/2022 | ABBV | Buy Now | AbbVie | $204.00 | -27.94% | Navin Jacob66% | $146 → $147 | Maintains | Neutral | Get Alert |
| 09/22/2022 | LLY | Buy Now | Eli Lilly | $820.60 | -55.76% | Navin Jacob66% | → $363 | Upgrade | Neutral → Buy | Get Alert |
| 11/29/2021 | ABBV | Buy Now | AbbVie | $204.00 | -36.76% | Navin Jacob66% | $126 → $129 | Maintains | Buy | Get Alert |
| 05/12/2021 | ABBV | Buy Now | AbbVie | $204.00 | -38.24% | Navin Jacob66% | $124 → $126 | Maintains | Buy | Get Alert |
| 12/11/2020 | ABBV | Buy Now | AbbVie | $204.00 | -39.22% | Navin Jacob66% | $118 → $124 | Maintains | Buy | Get Alert |
| 11/09/2020 | RPRX | Buy Now | Royalty Pharma | $31.37 | 62.58% | Navin Jacob66% | → $51 | Upgrade | Neutral → Buy | Get Alert |
| 06/30/2020 | ICPT | Buy Now | Intercept Pharma | — | — | Navin Jacob66% | $135 → $57 | Downgrade | Buy → Neutral | Get Alert |
| 06/17/2020 | ABBV | Buy Now | AbbVie | $204.00 | -46.57% | Navin Jacob66% | $96 → $109 | Maintains | Buy | Get Alert |
| 04/27/2020 | GILD | Buy Now | Gilead Sciences | $111.47 | — | Navin Jacob66% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/21/2020 | LLY | Buy Now | Eli Lilly | $820.60 | -80.75% | Navin Jacob66% | $157 → $158 | Downgrade | Buy → Neutral | Get Alert |
| 04/13/2020 | MRK | Buy Now | Merck & Co | $89.23 | 3.1% | Navin Jacob66% | $96 → $92 | Maintains | Buy | Get Alert |
| 04/13/2020 | ABBV | Buy Now | AbbVie | $204.00 | -52.94% | Navin Jacob66% | $106 → $96 | Maintains | Buy | Get Alert |
| 02/10/2020 | ABBV | Buy Now | AbbVie | $204.00 | -48.53% | Navin Jacob66% | $96 → $105 | Maintains | Buy | Get Alert |
| 02/06/2020 | MRK | Buy Now | Merck & Co | $89.23 | 7.59% | Navin Jacob66% | $99 → $96 | Maintains | Buy | Get Alert |
| 01/23/2020 | MRK | Buy Now | Merck & Co | $89.23 | 10.95% | Navin Jacob66% | $94 → $99 | Maintains | Buy | Get Alert |
| 11/12/2019 | ICPT | Buy Now | Intercept Pharma | — | — | Navin Jacob66% | $136 → $135 | Maintains | Buy | Get Alert |
| 10/17/2019 | LLY | Buy Now | Eli Lilly | $820.60 | -83.79% | Navin Jacob66% | $134 → $133 | Maintains | Buy | Get Alert |
| 05/02/2019 | MRK | Buy Now | Merck & Co | $89.23 | -1.38% | Navin Jacob66% | $87 → $88 | Maintains | Buy | Get Alert |
| 01/23/2019 | LLY | Buy Now | Eli Lilly | $820.60 | — | Navin Jacob66% | — | Initiates | → Buy | Get Alert |
| 01/23/2019 | ICPT | Buy Now | Intercept Pharma | — | — | Navin Jacob66% | — | Initiates | → Buy | Get Alert |
| 04/17/2015 | ICPT | Buy Now | Intercept Pharma | — | — | Navin Jacob66% | → $465 | Initiates | → Buy | Get Alert |
| 01/30/2013 | LLY | Buy Now | Eli Lilly | $820.60 | -93.42% | Navin Jacob66% | $51 → $54 | Maintains | Neutral | Get Alert |
| 01/07/2013 | LLY | Buy Now | Eli Lilly | $820.60 | -93.79% | Navin Jacob66% | $49 → $51 | Maintains | Neutral | Get Alert |
| 10/09/2012 | LLY | Buy Now | Eli Lilly | $820.60 | -94.03% | Navin Jacob66% | $45 → $49 | Maintains | Neutral | Get Alert |
| 09/21/2012 | LLY | Buy Now | Eli Lilly | $820.60 | -94.52% | Navin Jacob66% | $42 → $45 | Maintains | Neutral | Get Alert |
